ENTITY
JOINN Laboratories

JOINN Laboratories (6127 HK)

150
Analysis
Health Care • China
JOINN Laboratories is a specialized drug development outsourcing company (CRO) that provides non-clinical pharmacology and toxicology research and evaluation services, including drug safety assessment, pharmacodynamic, and pharmacokinetic studies. The company also offers clinical trial services and the production and sale of experimental models. Headquartered in Beijing, China, it was founded in 1995.
more
•08 Aug 2026 12:45

Primer: JOINN Laboratories (6127 HK) - Aug 2026

JOINN Laboratories is a leading non-clinical Contract Research Organization (CRO) in China, specializing in drug safety assessment. However,...

Logo
92 Views
Share
•24 Sep 2026 17:05

Technically Speaking Breakouts & Breakdowns - HONG KONG (September 2026)

The Hong Kong market continues to drift sideways this month, trading above its long-term support levels but unable to rally past strong resistance...

Logo
107 Views
Share
•02 Mar 2026 15:08

A/H Premium Tracker (Weeks Spanning Spring Festival to 27 Feb 2026)

AH spreads appear to be climbing, gently, still, continuing a months-long trend. But it isn't violent even if some specific AH premium spreads are.

Logo
395 Views
Share
•19 Jul 2026 17:41

China Healthcare Weekly Wrap (13-17 July)

Key news this week 1) Dizal/AZ USD1.5bn deal on EGFR inhibitor, 2) Hengrui's NewCo BraveHeart files for IPO; 3) Pharmaron and Joinn 1H26 results...

Logo
126 Views
Share
bullish•Macroeconomics
•16 Jul 2026 09:22•Broker

Quam Morning Note (16 Jul)

The HSI opened up 210 pts before extending gains, once rising 434 pts to a peak of 24,774. The index closed at 24,681, up 340 pts or 1.4%,...

Logo
108 Views
Share
x